Publications

Matt Weinzierl is Senior Associate Dean and Chair of the MBA Program at Harvard Business School, where he is the Joseph and Jacqueline Elbling Professor of Business Administration in the Business, Government, and the International Economy Unit, and a Research... View Details

Keywords: aerospace

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

2018
Book

Food Citizenship: Food System Advocates in an Era of Distrust

By: Ray A. Goldberg

The global food system is the largest segment of the world's economy. As agribusiness-studies pioneer Ray Goldberg suggests, it is also the largest health system on the planet. And it is changing fast. Its size and importance to human, environmental, and economic... View Details

Keywords: Food; System; Global Range; Health; Environmental Sustainability; Development Economics; Partners and Partnerships; Public Opinion; Agriculture and Agribusiness Industry; Food and Beverage Industry

09 Mar 2015
Research & Ideas

Why Entrepreneurs Should Go Work for Government

School who has created a new MBA course, Public Entrepreneurship. "The course allows students to consider the alternative that government can work—or they can help make it work." “We have many talented people in government, but... View Details

Keywords: by Michael Blanding

29 Oct 2015
News

Options to Promote Competitive Generics Markets in the United States

2020
Working Paper

What Can Economics Say About Alzheimer's Disease?

By: Amitabh Chandra, Courtney Coile and Corina Mommaerts

Alzheimer’s Disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the... View Details

Keywords: Health Disorders; Health Care and Treatment; Economics

September 2023
Article

Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic

By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard and Martial Foucault

We study the impact of public health messages on intentions to vaccinate and vaccination uptakes, especially among hesitant groups. We performed an experiment comparing the effects of egoistic and altruistic messages on COVID-19 vaccine intentions and behaviour. We... View Details

Keywords: COVID-19; Vaccination; Vaccine Hesitancy; Information Campaigns; Health Pandemics; Behavior; Information

Register to Read

2022
Working Paper

Social Protection and Social Distancing During the Pandemic: Mobile Money Transfers in Ghana

By: Dean Karlan, Matt Lowe, Robert Osei, Isaac Osei-Akoto, Benjamin N. Roth and Christopher Udry

We study the impact of mobile money transfers to a representative sample of low-income Ghanaians during the COVID-19 pandemic. The announcement of the upcoming transfers affects neither consumption, well-being, nor social distancing. Once disbursed,... View Details

Keywords: Social Distancing; Social Welfare; Economic Relief; Health Pandemics; Poverty

2020
Discussion Paper

Acting Now While Preparing for Tomorrow: Competitiveness Upgrading Under the Shadow of COVID-19

By: Christian H.M. Ketels and Peter Clinch

This paper aims to provide policy makers, especially those focused on the longer-term growth potential of their countries, with an initial framework to think about their action priorities in the context of the overall COVID-19 response. Our focus is on the... View Details

Keywords: Competitiveness; COVID-19 Pandemic; Competition; Government Administration; Health Pandemics; Economy; Supply Chain; Safety

March 2014 (Revised November 2020)
Case

The Novartis Malaria Initiative

By: Michael Chu, Vincent Marie Dessain and Emilie Billaud

The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details

Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria

Educators

Teaching Interest

Managing Global Health: Applying Behavioral Economics to Create Impact (MBA)

Health, and development more broadly, is not something we give to people: it is something they produce themselves, interacting with supply-side and institutional factors. This course trains students to see through the lens of the end-user and to use the levers of... View Details

August 2008 (Revised September 2009)
Case

Sex, Drugs, and Rock 'n Roll: The MTV Approach to Tackling HIV/AIDS

By: Tarun Khanna, Sonali R. Bloom and David E. Bloom

This case explores the role that MTV, with its heavy diet of music and general youth-oriented media content, plays in spreading public-service messaging to contain the scourge of HIV/AIDS worldwide. There is a focus especially on its efforts in several emerging... View Details

Keywords: For-Profit Firms; Developing Countries and Economies; Multinational Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Corporate Strategy; Health Industry; Africa

Educators

06 Sep 2019
Blog Post

The Business of Medicine: MD/MBA Students Having an Impact

These Harvard Medical School (HMS) students are already making a difference in the health care community. Now, they are at HBS fine-tuning their leadership skills in preparation of receiving their MD/MBA. Each year, MD/MBA applicants... View Details

17 Aug 2021
Research & Ideas

Can Autonomous Vehicles Drive with Common Sense?

Julian De Freitas. “We expect that they will make roads truly much safer.” In fact, De Freitas and colleagues recently argued in the Proceedings of the National Academy of Sciences that adopting driverless vehicles on a broad scale could improve global View Details

Keywords: by Michael Blanding; Auto

January 2018
Article

The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials

By: Aaron V. Kaplan and Ariel D. Stern

The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details

Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States

01 Sep 2023
Blog Post

Harvard Business School Announces 2023 Goldsmith Fellows

from the nonprofit and public sector to attend HBS, these fellowships enable the School to award $10,000 to a select number of incoming MBA students. Beginning with the Class of 1990, 257 incoming students have received the fellowship.... View Details

June 2020
Article

Real-time Data from Mobile Platforms to Evaluate Sustainable Transportation Infrastructure

By: Omar Isaac Asensio, Kevin Alvarez, Arielle Dror, Emerson Wenzel, Catharina Hollauer and Sooji Ha

By displacing gasoline and diesel fuels, electric cars and fleets reduce emissions from the transportation sector, thus offering important public health benefits. However, public confidence in the reliability of charging infrastructure remains a fundamental barrier to... View Details

Keywords: Environmental Sustainability; Transportation; Infrastructure; Behavior; AI and Machine Learning; Demand and Consumers

December 1994 (Revised March 1996)
Case

Ciba Consumer Pharmaceuticals' Acutrim: Challenges and Opportunities in Today's Diet Industry

By: Nancy F. Koehn and Rebecca Voorheis

Since its introduction in 1983, Acutrim has been a major player in the U.S. appetite suppressant market and in the broader diet industry. This case focuses on the strategic, regulatory, marketing, and financial challenges this product and the rapidly changing diet... View Details

Keywords: Product Marketing; Market Design; Industry Structures; Public Ownership; Problems and Challenges; Opportunities; Food and Beverage Industry; Pharmaceutical Industry; United States

Educators